These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2521899)

  • 1. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ; Schumacher WA
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
    Grover GJ; Sleph PG; Weiss HR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diltiazem on infarct size, reperfusion flow and flow reserve: the effect of timing of treatment.
    Grover GJ; Sleph PG; Parham CS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):263-9. PubMed ID: 3392657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
    Grover GJ; Schumacher WA; Simon M; Parham C
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ; Parham CS; Schumacher WA
    Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
    Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
    J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
    Grover GJ; Schumacher WA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs.
    Pelc LR; Farber NE; Warltier DC; Gross GJ
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):586-93. PubMed ID: 2470996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
    Schumacher WA; Heran CL; Hartl KS; Ogletree ML
    J Pharmacol Exp Ther; 1990 May; 253(2):841-6. PubMed ID: 2140131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of thromboxane A2 in reperfusion injury.
    Grover GJ; Sleph PG; Parham C
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):504-8. PubMed ID: 2971219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
    Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.
    Auchampach JA; Maruyama M; Cavero I; Gross GJ
    J Pharmacol Exp Ther; 1991 Dec; 259(3):961-7. PubMed ID: 1762089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
    Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
    Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey.
    Schumacher WA; Goldenberg HJ; Harris DN; Ogletree ML
    J Pharmacol Exp Ther; 1987 Nov; 243(2):460-6. PubMed ID: 2960794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.
    Black SC; Schasteen CS; Weiss RH; Riley DP; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1208-15. PubMed ID: 7932173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogs.
    Grover GJ
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):56-60. PubMed ID: 2529546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
    Rousseau G; Provost P; Tran D; Caillé G; Latour JG
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.